Bioequivalence Study of Two Treatments for the Treatment of Plaque Psoriasis

Exclusion Criteria

• •1. Pregnant, breastfeeding or planning a pregnancy within the period of their study participation period.
• •2. Current diagnosis of unstable forms of psoriasis in the treatment area.
• •3. History of unresponsiveness to topical treatment for psoriasis
• •4. Presence of any other skin condition that, in the Investigator's opinion, might interfere with psoriasis diagnosis and/or evaluations
• •5. Any uncontrolled, chronic or serious disease or medical condition that would prevent participation in a clinical trial, or, in judgment of the investigator, would put the subject at undue risk or might confound the study assessments
• •6. Use of medicated make-up throughout the study and significant change in the use of consumer products within 30 days (1 month) of study entry and throughout the study
• •7. Subject consumes excessive alcohol, abuses drugs, or has a condition that could compromise the subject's ability to comply with study requirements.
• •8. Subjects who in the opinion of the investigator, are unlikely to be able to follow the restrictions of the protocol and complete the study